North America enteral nutrition market is expected to grow by 7.3% annually in the forecast period and reach $5,873.8 million by 2030 driven by rising number of patients suffering with chronic diseases and surge in adoption of enteral nutrition amid COVID-19 pandemic. Highlighted with 27 tables and 52 figures, this 112-page report “North America Enteral Nutrition Market 2020-2030 by Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America enteral nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America enteral nutrition market in every aspect of the classification from perspectives of Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Country. Based on Nutrient, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Protein Based Nutrition • Standard Protein Diet • High Protein Supplement • Protein for Diabetic Patients • Other Protein-based Nutitions Carbohydrates Based Nutrition Fat Based Nutrition Vitamin Based Nutrition Other Nutrition Types
Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally
Download SampleBased on Application, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Critical Care • Diabetes • Neurology • Oncology • Other Applications Based on Category, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Enteral Nutrition for Chronic Illness • Enteral Nutrition with Standard Formula Based on Product Form, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Liquid Enteral Nutrition • Powder Enteral Nutrition
Based on End User, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Pediatric • Adults • Geriatric Based on Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Distribution by Hospitals • Distribution by Retail Pharmacies • Distribution by Online Pharmacies Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Nutrient, Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in North America enteral nutrition market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Abbott Laboratories B. Braun Melsungen AG Baxter International, Inc. Danone S.A. Fresenius Kabi AG North America Health Products, Inc. Hormel Foods Corporation Mead Johnson Nutrition Company Meiji Holdings Co., Ltd. Nestle S.A. Reckitt Benckiser Group LLC Victus, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
We are friendly and approachable, give us a call.